The DOI matches its Crossref record.
Mutant Huntingtin Impairs Vesicle Formation from Recycling Endosomes by Interfering with Rab11 Activity
Abstract
Huntingtin (Htt) localizes to endosomes, but its role in the endocytic pathway is not established. Recently, we found that Htt is important for the activation of Rab11, a GTPase involved in endosomal recycling. Here we studied fibroblasts of healthy individuals and patients with Huntington's disease (HD), which is a movement disorder caused by polyglutamine expansion in Htt. The formation of endocytic vesicles containing transferrin at plasma membranes was the same in control and HD patient fibroblasts. However, HD fibroblasts were delayed in recycling biotin-transferrin back to the plasma membrane. Membranes of HD fibroblasts supported less nucleotide exchange on Rab11 than did control membranes. Rab11-positive vesicular and tubular structures in HD fibroblasts were abnormally large, suggesting that they were impaired in forming vesicles. We used total internal reflection fluorescence imaging of living fibroblasts to monitor fluorescence-labeled transferrin-carrying transport intermediates that emerged from recycling endosomes. HD fibroblasts had fewer small vesicles and more large vesicles and long tubules than did control fibroblasts. Dominant active Rab11 expressed in HD fibroblasts normalized the recycling of biotin-transferrin. We propose a novel mechanism for cellular dysfunction by the HD mutation arising from the inhibition of Rab11 activity and a deficit in vesicle formation at recycling endosomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The HD mutation reduces the production of active rab11, thereby slowing endosomal recycling of receptors and transporters to the cell surface.
“The HD mutation is known to reduce the production of active rab11, thereby slowing endosomal recycling of receptors and transporters to the cell surface [23-26].”
From Glucose transporter 3 is a rab11-dependent trafficking cargo and its transport to the cell surface is reduced in neurons of CAG140 Huntington’s disease mice (2014) · cites this paper as [24]
Diminished rab11 activity in HD cells affects the recycling of transferrin receptor and neuronal glutamate/cysteine transporter EAAC1.
“Rab11 regulates numerous receptors and transporters trafficking onto cell surfaces; its diminished activity in HD cells affects the recycling of transferrin receptor and neuronal glutamate/cysteine transporter EAAC1.”
From Glucose transporter 3 is a rab11-dependent trafficking cargo and its transport to the cell surface is reduced in neurons of CAG140 Huntington’s disease mice (2014) · cites this paper as [24]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 55
- 10.1016/j.bbrc.2008.07.009 · DOI
- 10.1083/jcb.125.1.67 · DOI
- 10.1083/jcb.124.1.83 · DOI
- 10.1074/jbc.M511370200 · DOI
- 10.1111/j.1365-2818.2006.01706.x · DOI
- 10.1016/S0092-8674(03)01079-1 · DOI
- 10.1016/0092-8674(92)90306-W · DOI
- 10.1016/j.tcb.2006.08.002 · DOI
- 10.1038/sj.cdd.4401967 · DOI
- 10.1007/s11064-006-9110-2 · DOI
- 10.1091/mbc.e08-07-0726 · DOI
- 10.1016/0896-6273(95)90346-1 · DOI · Paper page
- 10.1083/jcb.140.3.603 · DOI
- 10.1093/hmg/6.13.2205 · DOI
- 10.1016/j.cell.2004.06.018 · DOI · Paper page
- 10.1111/j.1471-4159.2007.04881.x · DOI
- 10.1006/bbrc.1997.7520 · DOI
- 10.1083/jcb.109.6.2703 · DOI
- 10.1073/pnas.0601617103 · DOI · Paper page
- 10.1146/annurev.bioeng.10.061807.160431 · DOI
- 10.1016/S0896-6273(03)00594-4 · DOI
- 10.1016/S0968-0004(03)00168-3 · DOI
- 10.1016/S0960-9822(00)00864-2 · DOI
- 10.1242/jcs.109.6.1215 · DOI
- 10.1091/mbc.e02-01-0025 · DOI · Paper page
- 10.1083/jcb.125.6.1265 · DOI
- 10.1091/mbc.9.10.2819 · DOI
- 10.1523/JNEUROSCI.20-19-07268.2000 · DOI · Paper page
- 10.1073/pnas.0400243101 · DOI
- 10.1083/jcb.200807023 · DOI
- 10.1523/JNEUROSCI.18-04-01261.1998 · DOI
- 10.1097/WNR.0b013e328315cd4c · DOI
- 10.1038/nn1988 · DOI
- 10.1038/nrm1315 · DOI · Paper page
- 10.1074/jbc.M509806200 · DOI
- 10.1083/jcb.200509091 · DOI
- 10.1146/annurev.biochem.76.061705.130002 · DOI
- 10.1073/pnas.95.11.6187 · DOI · Paper page
- 10.1083/jcb.200305115 · DOI
- 10.1016/j.ceb.2004.06.014 · DOI
- 10.1002/ana.20207 · DOI · Paper page
- 10.1083/jcb.150.5.1137 · DOI
- 10.1083/jcb.145.1.123 · DOI · Paper page
- 10.1016/S0896-6273(03)00569-5 · DOI
- 10.1128/MCB.24.18.8195-8209.2004 · DOI · Paper page
- 10.1093/hmg/ddl434 · DOI
- 10.1083/jcb.135.4.913 · DOI · Paper page
- 10.1523/JNEUROSCI.3355-05.2005 · DOI · Paper page
- 10.1128/MCB.26.1.303-312.2006 · DOI
- 10.1096/fj.03-0079fje · DOI
- 10.1006/exnr.1998.6832 · DOI · Paper page
- 10.1091/mbc.e03-10-0737 · DOI
- 10.1091/mbc.e07-12-1296 · DOI
- 10.1083/jcb.151.6.1207 · DOI · Paper page
- 10.1038/35052055 · DOI · Paper page
Cited by
Sorted by citations
Dendritic spine loss and neurodegeneration is rescued by Rab11 in models of Huntington's disease
Richards, P., Didszun, C., Campesan, S., Simpson, A., Horley, B., Young, K. W., Glynn, P., Cain, K., Kyriacou, C. P., Giorgini, F., et al. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.127 · Cited by 82
White, J. A., Anderson, E., Zimmerman, K., Zheng, K. H., Rouhani, R., & Gunawardena, S. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv415 · Cited by 67
McClory, H., Williams, D., Sapp, E., Gatune, L. W., Wang, P., DiFiglia, M., & Li, X. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0178-7 · Cited by 60
Self-citationAxonopathy in Huntington's disease
Li, J.-Y., & Conforti, L. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.08.010 · Cited by 55
The long and the short of aberrant ciliogenesis in Huntington disease
Liu, J.-P., & Zeitlin, S. O. (2011) · Journal of Clinical Investigation · doi:10.1172/jci60243 · Cited by 19
Metadata
- Authors
- Li, X., Standley, C., Sapp, E., Valencia, A., Qin, Z.-H., Kegel, K. B., Yoder, J., Comer-Tierney, L. A., Esteves, M., Chase, K., Alexander, J., Masso, N., Sobin, L., Bellve, K., Tuft, R., Lifshitz, L., Fogarty, K., Aronin, N., & DiFiglia, M.
- Affiliations
- Cellular Neurobiology Laboratory and Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129
- Biomedical Imaging Group, Department of Physiology, University of Massachusetts Medical School
- Department of Medicine and Cell Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01655
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2009-11-01
- Volume
- 29
- Issue
- 22
- Pages
- 6106-6116
- ISSN
- 1098-5549
- Cited by
- 105
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review